Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| ? | VIKING GLOBAL INVESTORS LP | 18.56M | $1.46B | - |
| ? | BridgeBio Pharma LLC | 14.59M | $1.15B | - |
| ? | HOMCY CHARLES J | 916.7K | $72.07M | - |
| Dir | MCCORMICK FRANK | 766.6K | $60.27M | - |
| CEO | | 763.2K | $60.00M | - |
Transactions
50 transactions · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2025-11-06 | Kumar Neil | Chief Executive Officer | Sell | 14,695 | $63.55 | $933,888.04 | -0.3% | → |
| 2025-10-29 | MCCORMICK FRANK | Director | Sell | 198,359 | $66.58 | $13,206,527.70 | -5.2% | → |
| 2025-10-27 | MCCORMICK FRANK | Director | Sell | 1,641 | $65.00 | $106,665.00 | -0.2% | → |
| 2025-10-09 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $54.79 | $4,383,442.21 | -0.5% | → |
| 2025-09-05 | MCCORMICK FRANK | Director | Sale+OE | 74,000 | $53.16 | $3,933,544.00 | -47.1% | → |
| 2025-09-05 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $52.20 | $4,175,835.24 | -0.3% | → |
| 2025-08-21 | Trimarchi Thomas | President and CFO | Sell | 42,237 | $49.48 | $2,090,081.05 | -9.1% | → |
| 2025-08-20 | Kumar Neil | Chief Executive Officer | Sell | 26,156 | $48.82 | $1,276,927.17 | -5.5% | → |
| 2025-08-18 | Trimarchi Thomas | President and CFO | Sell | 17,353 | $50.23 | $871,722.42 | -1.8% | → |
| 2025-08-11 | HOMCY CHARLES J | Director | Sell | 300,000 | $46.37 | $13,912,442.76 | -9.4% | → |
| 2025-08-08 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $45.84 | $3,666,949.26 | -0.4% | → |
| 2025-08-07 | Apuli Maricel | Chief Accounting Officer | Sell | 1,000 | $45.44 | $45,440.00 | -0.7% | → |
| 2025-08-05 | Ellis Andrea | Director | Sale+OE | 17,167 | $49.00 | $841,183.00 | -48.0% | → |
| 2025-07-02 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $42.63 | $3,410,450.42 | -0.5% | → |
| 2025-06-27 | VIKING GLOBAL INVESTORS LP | - | Sell | 3,500,000 | $44.00 | $154,000,000.00 | -15.9% | → |